Login

Matt Brown, CFO of Livetiles Ltd (ASX: LVT), discussed with Satori Fund's Founder Dan Niles about energy prices being a significant concern. 00:10:00

Share On Facebook Share On Twitter

LiveTiles is managed by CEO David Vander.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
"Scott Kleinman of Apollo Management on Market Sentiment, Fed Policy, and Global Outlook"
00:10:00
where it currently exists versus Where the world is headed |Peter C. Lewis,CHAIRMAN,Wharton Equity Partners
00:10:00
Freshworks Customer Story - Descartes System Group Inc | Edward J. Ryan , CEO, Descartes Systems Group IncDSG:TOR
00:10:00
Capricorn Metals Overview and Project Development Update
00:10:00
Hans Wallenstam Reflects on Wallenstam's Strong Growth and Strategic Future | Hans Wallenstam, CEO, Wallenstam AB.
00:10:00
Managing Employee Uncertainty During Mergers and Transformations
00:10:00
Tal Jacobson, Perion CEO, joins 'Squawk Box' to discuss Snap's quarterly earnings results and market implications.
00:10:00
Focuses on early stage investments in technology companies|Mike Maples Jr,Founding Partner,Floodgate
00:10:00
Key Economic Trends from Q1 2024 |Christine A. Centeno, Founder, Simplicity Wealth Management LLC.
00:10:00
focusing on early-stage companies working on emergent tech|Mike W. Erwin,Founder, General Partner, and Chief Investment Officer,Ecliptic Capital
00:10:00
Inside Google: Sundar Pichai on AI, Innovation, and the Future| Sundar Pichai, CEO, Google
00:10:00
Gives us an update on what he's been busy with and why there hasn't been a new episode for a few weeksDr James R. McIlroy , CEO OF ENTEROBIOTIX

© 2026 Nehu